Literature DB >> 13364418

The hypotensive action of mercamylamine.

A E DOYLE, E A MURPHY, G H NEILSON.   

Abstract

Entities:  

Keywords:  AUTONOMIC DRUGS/therapeutic use; HYPERTENSION/therapy

Mesh:

Substances:

Year:  1956        PMID: 13364418      PMCID: PMC2035783          DOI: 10.1136/bmj.2.5003.1209

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  Methonium treatment of severe and malignant hypertension.

Authors:  J McMICHAEL; E A MURPHY
Journal:  J Chronic Dis       Date:  1955-05

2.  Drug therapy in hypertension; a critical review.

Authors:  A E DOYLE; F H SMIRK
Journal:  Practitioner       Date:  1955-02

3.  Pharmacology of mecamylamine.

Authors:  R V FORD; J C MADISON; J H MOYER
Journal:  Am J Med Sci       Date:  1956-08       Impact factor: 2.378

4.  A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients.

Authors:  E D FREIS; E A PARTENOPE; L S LILIENFIELD; J C ROSE
Journal:  Circulation       Date:  1954-04       Impact factor: 29.690

5.  Comparison of oral and subcutaneous administration of methonium salts in the treatment of high blood-pressure.

Authors:  J A KILPATRICK; F H SMIRK
Journal:  Lancet       Date:  1952-01-05       Impact factor: 79.321

6.  Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A).

Authors:  F H SMIRK
Journal:  Lancet       Date:  1953-03-07       Impact factor: 79.321

  6 in total
  4 in total

1.  Excretion of mecamylamine after intravenous and oral administration.

Authors:  K D ALLANBY; J R TROUNCE
Journal:  Br Med J       Date:  1957-11-23

2.  Pempidine for Hypertension.

Authors:  K Somers
Journal:  Br Med J       Date:  1961-01-07

3.  The introduction of ganglion blocking drugs for the treatment of hypertension.

Authors:  A E Doyle
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

4.  DEPRESSION OF THE VASOMOTOR CENTRE BY MECAMYLAMINE, INDEPENDENT OF ITS GANGLION-BLOCKING ACTIVITY.

Authors:  K P BHARGAVA; K N DHAWAN
Journal:  Br J Pharmacol Chemother       Date:  1963-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.